Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MYOS

MYOS RENS Technology (MYOS) Stock Price, News & Analysis

About MYOS RENS Technology Stock (NASDAQ:MYOS)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$1.01
$11.40
52-Week Range
N/A
Volume
N/A
Average Volume
1.68 million shs
Market Capitalization
$16.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

MedAvail Holdings, Inc. is a technology-enabled pharmacy company. It provides turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. The firm helps patients to optimize drug adherence, resulting in better health outcomes. The company is headquartered in Mississauga, Canada.

Receive MYOS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MYOS RENS Technology and its competitors with MarketBeat's FREE daily newsletter.

MYOS Stock News Headlines

Trump’s Bitcoin Reserve is No Accident…
Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new blockchain development…
Bio-active Peptides Market Size Dynamics 2023-2029
See More Headlines

MYOS Stock Analysis - Frequently Asked Questions

MYOS RENS Technology Inc. (NASDAQ:MYOS) announced its quarterly earnings data on Tuesday, August, 6th. The company reported ($0.13) EPS for the quarter, missing analysts' consensus estimates of ($0.12) by $0.01. The firm earned $0.15 million during the quarter, compared to the consensus estimate of $0.14 million. MYOS RENS Technology had a negative net margin of 277.82% and a negative trailing twelve-month return on equity of 166.68%.

Based on aggregate information from My MarketBeat watchlists, some other companies that MYOS RENS Technology investors own include Chesapeake Energy (CHKAQ), Catalyst Pharmaceuticals (CPRX), Ampio Pharmaceuticals (AMPE), Biocept (BIOC), T2 Biosystems (TTOO), AbbVie (ABBV) and Global Blood Therapeutics (GBT).

Company Calendar

Last Earnings
8/06/2019
Today
5/03/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:MYOS
Fax
N/A
Employees
15
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-4,260,000.00
Net Margins
-277.82%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.03 million
Price / Cash Flow
N/A
Book Value
$0.13 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$16.70 million
Optionable
Not Optionable
Beta
1.08
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:MYOS) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners